ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 129 filers reported holding ALLAKOS INC in Q1 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,321,675 | -46.9% | 4,987,522 | +2.0% | 28.00% | +18.5% |
| Q2 2023 | $21,311,384 | -2.0% | 4,887,932 | 0.0% | 23.64% | -6.1% |
| Q1 2023 | $21,751,297 | -47.1% | 4,887,932 | 0.0% | 25.16% | -47.6% |
| Q4 2022 | $41,156,388 | +37.6% | 4,887,932 | 0.0% | 48.01% | +38.2% |
| Q3 2022 | $29,914,000 | +95.5% | 4,887,932 | 0.0% | 34.73% | +54.5% |
| Q2 2022 | $15,299,000 | -45.1% | 4,887,932 | 0.0% | 22.48% | -21.4% |
| Q1 2022 | $27,861,000 | -41.8% | 4,887,932 | 0.0% | 28.60% | -16.2% |
| Q4 2021 | $47,853,000 | -90.8% | 4,887,932 | 0.0% | 34.14% | -60.7% |
| Q3 2021 | $517,485,000 | +24.0% | 4,887,932 | 0.0% | 86.88% | +6.5% |
| Q2 2021 | $417,283,000 | -25.6% | 4,887,932 | 0.0% | 81.57% | -5.6% |
| Q1 2021 | $561,037,000 | -30.3% | 4,887,932 | -15.0% | 86.41% | -2.3% |
| Q4 2020 | $805,071,000 | – | 5,750,506 | – | 88.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 4,887,932 | $29,914,000 | 34.73% |
| Logos Global Management LP | 5,936,666 | $36,332,000 | 4.47% |
| TCG Crossover Management, LLC | 1,643,500 | $10,058,000 | 3.02% |
| Vivo Capital, LLC | 4,120,134 | $25,215,000 | 2.78% |
| Ally Bridge Group (NY) LLC | 598,172 | $3,661,000 | 2.42% |
| Frazier Life Sciences Management, L.P. | 4,792,000 | $29,327,000 | 2.26% |
| NEA Management Company, LLC | 6,148,704 | $33,867,000 | 1.69% |
| COMMODORE CAPITAL LP | 1,643,500 | $10,058,000 | 1.62% |
| BVF INC/IL | 5,006,921 | $30,642,000 | 1.27% |
| Deep Track Capital, LP | 4,518,575 | $27,654,000 | 1.27% |